Archives of Liver Cancer & Pancreatic

I am a consultant clinical oncologist at the Christie Hospital and have site specialist interest in O-G and HPB cancer treatments. I am in involved in clinical research and have supported the development of a few UK precision radiation therapy trials for HPB cancers. I am the clinical lead for the SABR programme and Proton […]

Anita Balakrishnan is a Consultant Hepatopancreatobiliary (HPB) Surgeon at the Cambridge Hepatopancreatobiliary Unit, and Associate Lecturer at the University of Cambridge. Her academic research interest focuses on the investigation of the evolution of pancreatic ductal adenocarcinoma via a transgenic study of the role of DNA damage repair in the development of pancreatic cancer at the […]

After qualifying in medicine and surgery in 1986, Professor Bridgewater specialised in medical oncology at the Middlesex, Mount Vernon and Royal Marsden Hospitals. He undertook a PhD in gene therapy at the Institute of Cancer Research, and subsequently took a senior lecturer position in medical oncology at UCL in 1999. Professor Bridgewater leads the National […]

Dr David Chang is a Reader in Surgery at University of Glasgow. His research focus on the development and implementation of novel therapeutic strategies for pancreatic cancer particularly around DNA-damage response deficiency, by utilising molecular biomarkers of therapeutic response. Dr Chang undertook his pancreatic surgical fellowship, PhD, and post-doctoral training in Australia. He was recruited […]

Professor Eithne Costello gained her B.Sc. (Hons) in Pharmacology, at University College Dublin in 1988, and then undertook a cancer-based molecular biology PhD (1993), at University College Dublin, spending one-year of her Ph.D. research time at the University of Berne, Switzerland. She remained in Switzerland for a further six years where she was a postdoctoral […]